Conmed Corp (CNMD) Reports In-Line Q2 EPS; Lowers FY14 Outlook
Get Alerts CNMD Hot Sheet
Price: $47.68 --0%
Revenue Growth %: -0.5%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
OMID, SICP, SCKT, More
Revenue Growth %: -0.5%
Financial Fact:
Net sales: 184.79M
Today's EPS Names:
OMID, SICP, SCKT, More
Join SI Premium – FREE
Conmed Corp (NASDAQ: CNMD) reported Q2 EPS of $0.47, in-line with the analyst estimate of $0.47. Revenue for the quarter came in at $188.2 million versus the consensus estimate of $190.62 million.
Conmed Corp sees FY2014 EPS of $1.85-$1.95, versus prior guidance of $1.9-$2 and the consensus of $1.94. Conmed Corp sees FY2014 revenue of $735-745 million, versus prior guidance of $770-780 million and the consensus of $766.27 million.
For earnings history and earnings-related data on Conmed Corp (CNMD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- CTS Corp. (CTS) Tops Q3 EPS by 10c ; Offers Guidance
- Euronet Worldwide (EEFT) Misses Q3 EPS by 14c
- SoFi Technologies (SOFI) Tops Q3 EPS by 1c, Offers Guidance
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!





Tweet
Share